INTRODUCTION
Nuclear bodies (NB) are nuclear structures similar to cytoplasmic organelles such as mitochondrion, Golgi organelles, and lysosomes. NBs differ from cytoplasmic organelles in one important aspect, in that while cytoplasmic organelles are enclosed by a membrane and have, to a significant extent, a relatively well-defined composition, NBs are not encapsulated by a membrane, and as a result, they have a more dynamic composition that is influenced by intracellular as well as extracellular milieu (1) (2) (3) . In mammalian cells, the best known NBs are nucleoli, Cajal Bodies (CB), and Promyelocytic Leukemia nuclear bodies (PML-NBs). Nucleoli and CBs are involved in ribosomal RNA and small nuclear RNA biosynthesis and processing, respectively. PML-NBs are involved in maintenance of genome stability under physiological conditions and in DNA repair and apoptosis under conditions of genotoxic stress.
Plant cells have nuclear bodies as well, and upon light exposure, plant proteins involved in photosensory functions form a unique class of nuclear bodies with properties quite similar to mammalian NBs (4-7). The plant NBs that are formed following light exposure are referred to as photobodies (PB) (4) . Among plant photosensory proteins, the red light receptor phytochromes (PHY) are the most extensively studied with respect to photobody formation. More recently, it has been found that the blue light photosensory receptor cryptochrome (CRY) forms photobodies as well (8, 9) .
The compositions of PHY-PB and CRY-PB and the role of PB formation in signaling by these photoreceptors are not known. A genetic screen has identified several genes that are required for PHY-PB formation and one of these proteins, Hemera, has been found to associate with PHYPBs (10) . CRY-PBs have been mostly analyzed using AtCRY2 (8, 9) . Recent work suggests that AtCRY2 controls signaling pathways by two mechanisms (11) . In one mechanism, AtCRY2 binds to a bHLH-family member, the CIB transcription factor, upon excitation by blue light and promotes transcription of cognate promoters (11) . In the second mechanism, AtCRY2 binds to the COP1 (constitutively photomorphogenic 1) E3 ligase through a light-activated and SPA1 (suppressor of phytochrome A) protein-mediated mechanism forming a ternary CRY2-SPA1-COP1 complex and photobodies. Within photobodies, the E3 ligase activity of COP1 on cognate transcription factors that mediate the blue light response, such as flowering, is inhibited which leads to accumulation of these factors and upregulation of blue-light responsive genes (12) (13) (14) . In addition, within CRY2-PBs, COP1 ubiquitylates AtCRY2 leading to its eventual proteolysis and downregulation of the blue-light signaling pathway.
Humans have two CRY homologues (15, 16) . Even though both exhibit a high degree of sequence similarity with Arabidopsis CRYs, there is no convincing experimental evidence suggesting that human CRYs, which function as core circadian clock proteins, mediate any blue-light sensory activity (15, 16) . Hence, we reasoned that human cells could be used to determine the requirements for photobody formation by AtCRY2. We find that blue light stimulates hCOP1-AtCRY2 binding in the absence of SPA1 and leads to formation of CRY-PBs in which AtCRY2 is subject to proteolysis. We conclude that AtCRY2-PB formation does not depend on other plant proteins or nucleic acids. Using AtCRY2-human checkpoint fusion proteins, we demonstrate that we can regulate human DNA damage checkpoint responses by sequestering and concentrating the relevant proteins with blue-light pulses.
EXPERIMENTAL PROCEDURES
Plasmid Construction. Plasmids used in this work can be obtained from Addgene with detailed sequence information. To generate pEGFP-N1-AtCry2, AtCRY2 was amplified by PCR and inserted into pEGFP-N1 vector (Clontech). To generate pEGFP-N1-mCry2, mCRY2 was amplified by PCR and inserted into pEGFP-N1 vector. pEGFP-N1-DmCry was generated by subcloning the SpeI-XhoI fragment from pFastBac-DmCry (17) into the pEGFP-N1 vector. To generate pmCherry-N1-mCOP1, mCOP1 was amplified by PCR and inserted into the pmCherry-N1 (Clontech) vector. To generate pcDNA3.1-AtCry2-GFP-TopBP1, TopBP1 from LacRTopBP1 (18) was amplified by PCR and cloned into the Not1/Pme1 sites of pcDNA3.1-AtCry2-GFP plasmid. To generate pcDNA5/FRT/TOAtCRY2-EGFP, AtCRY2-EGFP fragment was amplified from pEGFP-N1-AtCRY2 by PCR. Then, the PCR product was inserted into pcDNA5/FRT/TO vector (Invitrogen).
All plasmid sequences were verified by sequencing at the Genome Analysis Facility at the University of North Carolina at Chapel Hill. Primer sequences used for PCR will be provided upon request.
Cell Lines. HEK293T and Flp TM -In T-REx TM -293 cells (Invitrogen) were maintained in Dulbecco's minimal essential medium supplemented with 10% fetal bovine serum and penicillin-streptomycin. The Flp-In/Flag-AtCRY2-EGFP cell line was generated according to the manufacturer's protocols (Invitrogen).
Immunoprecipitation. Flp-in/Flag-AtCRY2-EGFP cells were treated with 0.5 µg/ml tetracycline and continuously cultured in the dark for 48 hrs. Then the cells were exposed to 366 nm light (1) (2) ) and harvested at the indicated time points. Cells were lysed with PBS (Phosphate Buffered Saline) buffer containing 0.5% Triton X-100 and protease inhibitors (Roche), followed by two rounds of freeze-thaw cycles. Equal amounts of protein were incubated with anti-Flag M2 agarose beads (Sigma) for 2 hrs at 4 o C. Beads were washed three times with lysis buffer; bound proteins were eluted in 2X SDS-sample buffer and analyzed by immunoblotting.
Fluorescence Microscopy. For GFP Fluorescence Microscopy, HEK293T cells were cultured on Poly-D-Lysine Cellware 12 mm round coverslips (BD Bioscience) placed in 35 mm dishes. Cells were transfected with indicated plasmids using Lipofectamine 2000 reagent (Invitrogen). After 24 hrs incubation at 37 o C, cells were exposed to 366 nm light (2 mW cm -2 ) from BLAK-Ray long wave UV lamp (UVP) for the indicated time points. We obtained the same results with a lamp emitting mainly at 470 nm (blue light), but we performed most of our expriments with the BLAK-Ray long wave UV lamp emitting mainly at 366 nm which we will refer to as blue light for simplicity. The cells were washed twice with PBS, fixed immediately with 3.7% methanol-free formaldehyde in PBS for 15 min and washed twice with PBS. For GFP (FITC) and mCherry fluorescence imaging, the cells were washed three times and mounted in Prolong Gold Antifade with DAPI reagent.
For PML body immunofluorescene staining, cells were permeabilized by PBT (0.1% Triton X-100 in PBS) after fixation and blocked with antibody blocking buffer (1% BSA/in PBT) for 1 hr and incubated with anti-PML (2 µg/ml) antibody (Santa Cruz Biotechnology) for 45 min. After washing three times with PBT, the cells were incubated with Alexa Fluor 594 (1:500 dilution) (goat anti-mouse IgG, Invitrogen) secondary antibody for 30 min. Then the cover slip was washed three times and mounted in Prolong Gold Antifade with DAPI reagent. Images were captured using a LeicaSP2 confocal microscope. Protein proximity index (PPI) was calculated by using PPA software (http://www.anes.ucla.edu/~wuyong/) (24) .
Light-Induced in Vivo Proteolysis of CRYs. HEK293T cells (~90% confluency) were transfected with 2 µg appropriate plasmid DNA using Lipofectamine 2000 reagent (Invitrogen) in 35 mm dishes. The cells were kept in dark for 24 hrs and then exposed to blue light at a fluence rate of 2 mWcm -2 for the indicated periods (19) . The extent of photoinduced proteolysis was determined by Western blotting using appropriate antibodies, and the level of CRY proteolytic degradation was quantified using ImageQuant 5.0 (Molecular Dynamics) software after scanning the immunoblots.
Checkpoint Response Assay. HEK293T cells (~90% confluency) were transfected in 35 mm dishes using Fugene HD (Promega) and increasing amounts of plasmid DNA expressing AtCry2-GFP-TopBP1 fusions. Total transfected DNA was maintained constant in each dish by addition of pcDNA3.1 empty vector. After incubation for 18hrs, cells were exposed to blue light for 1 hr, incubated for a further 1hr at 37°C, and then the cells were harvested, lysed, and cell lysates were separated by SDS-PAGE. Chk1 phosphorylation was detected by immunoblotting using Ser345 phospho-ChK1 antibodies (Cell Signaling), and the levels of total Chk1 protein were subsequently detected by immunoblotting with anti-Chk1 antibodies (Santa Cruz Biotechnology) using the same membrane. Levels of phosphorylation were quantified using ImageQuant 5.0 (Molecular Dynamics) software after scanning the immunoblots. The highest level of Chk1 phosphorylation in each experiment was set equal to 100, and the levels of phosphorylated Chk1 in the other lanes were determined relative to this value. The averages from three independent experiments were graphed, and the error bars indicate the standard deviation (SD).
RESULTS
Formation of Cryptochrome Photobodies in Mammalian Cells. Although Cryptohromes from plant, insect and mammals exhibit highly conserved structures, they play diverse roles in light signal transduction pathways. Human cells possess cryptochrome 1 and 2 which are core circadian clock proteins, but are not known to have a photosensory function; they are not degraded following blue light exposure and are not known to form photobodies (16, 19) . In contrast, insect Type 1 CRYs including Drosophila CRY (DmCRY) and plant cryptochromes including AtCRY2 are degraded following blue light exposure and AtCRY2 forms photobodies prior to degradation in plant cells (11, 19) . We have previously shown that light-induced DmCRY proteolysis does not require any Drosophilaspecific protein, as it occurs when mammalian cells ectopically expressing DmCRY are exposed to blue light (19) . We wished to determine whether AtCRY2 would be similarly degraded by blue light in mammalian cells and if the degradation of both DmCRY and AtCRY2 proceeds through a prerequisite photobody formation as AtCRY2 does in plant cells.
To this end we constructed plasmids expressing AtCRY2-GFP, DmCRY-GFP and mouse mCRY2-GFP fusion proteins (Fig. 1A) , transfected human HEK293T cells with these plasmids which were then exposed to blue light and analyzed by fluorescence microscopy. As shown in Fig. 1B -D both AtCRY2-GFP and DmCRY-GFP are predominantly located in the nucleus, and prior to blue light exposure, exhibit uniform nuclear distribution. Similarly, mCRY2-GFP also appears to be exclusively in the nuclei (Fig 1C) . Exposure to blue light does not affect the nuclear localization patterns of DmCRY-GFP and mCRY2-GFP. In contrast, AtCRY2-GFP forms distinct photobodies following blue light exposure (Fig 1B) , quite similar to photobodies that form in plant cells. Two conclusions emerge from these findings. First, as evident from the behavior of DmCRY, not all photosensory CRYs make photobodies following light exposure. Second, and of special relevance, AtCRY2 forms photobodies in mammalian cells much in the same way as it does in plant cells, indicating that photobody formation does not require any plant-specific protein other than cryptochrome itself.
Light-induced Proteolysis of AtCRY2 in Mammalian Cells. As in all signal transduction systems, the phototransduction signal must be eventually downregulated to maintain the organismic homeostasis. Photosignaling initiated by DmCRY, as well as AtCRY2, are turned off by light-induced proteolysis of these cryptochromes (15, 19) . Previously we showed that light promotes DmCRY degradation in mammalian cells, indicating that no specific Drosophila protein is required for DmCRY proteolysis (19) . We wished to find out if AtCRY2 behaved in a similar manner. HEK293T cells expressing either AtCRY2-GFP or DmCRY-GFP were exposed to blue light for 1-4 hrs and the levels of these proteins were analyzed by immunoblotting. As seen in Fig. 2A both cryptochromes are degraded with similar kinetics, while mouse CRY2 which is not known to be a photosensory protein is not affected under similar conditions (19) , indicating that the light-induced proteolysis of certain cryptochromes represents a physiological step in their signaling pathways and is not caused by nonspecific protein degradation by toxic light doses. We also note that because DmCRY, which does not form PBs, and the photobody-forming AtCRY2 are both subject to light-induced proteolysis, these data indicate that PB formation is not an essential step on the pathway to proteolysis.
Kinetics of Formation and Resolution of AtCRY2 Photobodies. In plant cells, AtCRY2-GFP photobodies form in a light-dose-dependent manner and gradually disappear upon transfer from a light to dark environment (1, (20) (21) (22) . We wished to know if AtCRY2-GFP followed the same pattern in human cells. As seen in Fig. 2B after 30 min light exposure, a substantial amount of AtCRY2-GFP is in photobodies under our illumination conditions. After 60 min of blue light exposure, the majority of AtCRY2-GFP is in photobodies. When cells were then incubated in the dark, the number of photobodies gradually decreased over the course of 6 hrs, as has been observed in plant cells.
Because photobody formation entails clustering of the photosensory protein, and this process is expected to be dependent on the amount of the photoreceptor, we next investigated the effect of AtCRY2-GFP protein level on photobody formation. Flp-In/Flag-AtCRY2-EGFP cells stably expressing AtCRY2-GFP under a tetracycline-on promoter were treated with tetracycline for 12, 24, or 48 hrs, and exposed to blue light for 1 hr, and then analyzed by immunoblotting for AtCRY2-GFP expression and for photobody formation by fluorescence microscopy. As seen in Fig. 2C , AtCRY2-GFP steadily increases over the course of the experiment and the number of photobodypositive cells increases in parallel after blue light exposure. All these findings suggest that AtCRY2-GFP follows the same path for photobody formation in human cells as it does in plant cells.
Composition of AtCRY2 Photobodies in Mammalian Cells. All NBs characterized to date contain many types of proteins, up to 40 different proteins in PML-NBs (2,3). However, in general, the roles of the different types of proteins other than the defining member (PML in case of PMLNBs) in NB formation and function are not known. A genetic screen in Arabidopsis identified several proteins that were essential for phytochrome B photobody formation (10) . No such screen has been reported for AtCRY2. However, it has been found that light promotes binding of AtCRY2 to SPA1 which leads to formation of AtCRY2-SPA1-COP1 ternary complex and inhibition of E3 ligase activity of COP1 on transcription factors leading to the accumulation of these transcription factors and hence to blue-light specific gene expression pattern and phenotype (11, (20) (21) (22) . Humans do not possess an SPA1 homolog, and hence the pathway operative in plant cells for AtCRY2-COP1 interaction is not relevant in human cells. However, humans do have a COP1 homolog (23) which could potentially directly interact with AtCRY2. Thus, we wished to determine if AtCRY2 interacted with human COP1 and if this interaction was affected by light. To this end, we analyzed the effect of AtCRY2 on the subcellular distribution of COP1 in HEK293T cells. The cells were transfected with either mouse COP1-Cherry or AtCRY2-GFP plasmids (Fig 3A) , alone or in combination, and the cellular localizations of the two proteins before and after blue light exposure were analyzed by fluorescence microscopy. As seen in Fig. 3B , COP1 is uniformly distributed in the nucleus and cytoplasm and light exposure does not affect its distribution in the absence of AtCRY2. In contrast, AtCRY2-GFP, which is uniformly distributed in the nucleus in the dark, forms photobodies upon light exposure, as expected. Importantly, in cells transfected with both plasmids, even though in the dark both COP1 and AtCRY2 exhibit distribution similar to that when each protein is expressed alone, after light exposure most of AtCRY2 and a significant fraction of COP1 are in nuclear bodies and, within the resolution of our assay, all of the COP1 nuclear bodies overlap with AtCRY2 photobodies (Fig. 3C) . This is supported by the protein proximity index (PPI) analysis (24) which yields a value of 0.8, consistent with co-localization. Thus, it appears that even in the absence of SPA1, photoexcitation of AtCRY2 promotes its interaction with COP1. Since it has been reported that AtCRY2 interacts with COP1 only through intermediacy of SPA1 (14) we decided to analyze the AtCRY2-COP1 interaction identified by photobody analysis by an additional method, using immunoprecipitation.
Flp-In/Flag-AtCRY2-EGFP cells were induced with tetracycline for 48 hrs, irradiated with blue light for 5-60 min, and then lysed, and AtCRY2 was immunoprecipitated, and the immunoprecipitate was analyzed for COP1 by immunoblotting. As seen in Fig. 3D AtCRY2 binds to COP1 even in the dark and importantly this binding is stimulated by blue light by up to 2.5-fold. This finding suggests that light can stimulate direct AtCRY2-COP1 interaction in the absence of SPA1. However the possibility that this interaction is aided by a human protein that can substitute for SPA1 cannot be eliminated.
Specificity of Protein-protein Interactions within AtCRY2 photobodies. To ascertain that the AtCRY2-COP1 interaction we observe in AtCRY2 photobodies represents light-promoted specific protein-protein interactions and not bluelight stress-induced protein aggregation, we analyzed AtCRY2 photobodies for PML protein because this protein has been implicated in NBs that contributes to cellular responses to various stress conditions (2,3). PML-NBs are constitutively present in most human cell lines including HEK293T that is used in our study. To address a potential role for PML in formation of AtCRY2 PBs, HEK293T cells were transfected with AtCRY2-GFP plasmids and either kept in dark or exposed to blue light and analyzed for AtCRY2 by immunofluorescence staining and for PML by immunohistochemical staining. The results are shown in Fig. 4 . In the dark, AtCRY2-GFP exhibits uniform nuclear distribution as expected. In contrast, PML localizes to nuclear bodies, consistent with its known properties. Upon light exposure AtCRY2-GFP forms nuclear bodies and hence the nuclei of these cells contain two types of NBs, PML-NBs and AtCRY2-PB. Merging of the two images by using PPI analysis (24) yields a value of 0.4, which indicates that this overlap is within the limit of random overlap. Thus, we conclude that the AtCRY2-PBs are specific structures that form by light-induced association of AtCRY2 with itself and COP1 E3 ligase and represent a step on the AtCRY2 signaling pathway.
Use of Photobodies to Regulate Intranuclear Signaling Pathways. The sequestration of AtCRY2 by light in discreet nuclear bodies raised the potential that this property of cryptochrome could be used to control certain signaling pathways by light. Here, we attempted to initiate the ATR-mediated DNA damage checkpoint signaling pathway by blue light in the absence of DNA damage. ATR initiates the DNA damage checkpoint response by phosphorylating downstream targets in response to DNA damage by UV and UV-mimetic agents (25) . The TopBP1 protein, which contains multiple BRCT domains that are involved in protein-protein interactions, functions as an activator/mediator of ATR kinase function (26, 27) . Previously, it was shown that by fusing TopBP1 to the Lac repressor and targeting it to an array of tandem Lac operators stably inserted into the genome of NIH3T3 cells, ATR kinase was activated in the absence of DNA damage by sequestering it into a subnuclear region defined by the tandem array of Lac operators (18) . We reasoned that it might be possible to activate the ATR kinase by sequestering TopBP1 in the nucleus of mammalian cells in the form of photobodies.
To establish a system in which the ATR-initiated checkpoint is regulated by light, TopBP1 was fused to AtCRY2-GFP (Fig 5A) . HEK293T cells were transfected with this plasmid and exposed to blue light to induce photobody formation. As in the case of AtCRY2-GFP, the AtCRY2-GFPTopBP1 fusion protein efficiently forms photobodies upon blue light exposure (Fig 5B) . We hypothesized that the clustering of TopBP1 within these photobodies artificially increases the local concentration of the checkpoint protein complex and may activate the DNA damage checkpoint in the absence of DNA damage. As a readout, we measured the phosphorylation of Chk1 checkpoint signaling kinase, a major target of ATR in DNA damage checkpoint response (25) .
As seen in Fig 5C, blue light alone, in the absence of DNA damage, causes up to 5-fold increase in Chk1 phosphorylation in cells expressing AtCRY2-GFP-TopBP1 but not in AtCRY2-GFP expressing cells, indicating that AtCRY2-mediated clustering of TopBP1 is sufficient to activate the checkpoint response.
In conducting these experiments we were concerned about two potential sources of artifacts. First, it has been shown that transfecting cells with high levels of TopBP1-expressing plasmid can activate ATR in the absence of DNA damage (18, 27) . Secondly, high doses of blue light could generate reactive oxygen species from overexpressed flavoproteins, such as AtCRY2, which could cause DNA damage and activate DNA damage checkpoints (28) . To address these potential problems we carried out two types of controls. First, we used high levels of AtCRY2-GFP in transfection assays in parallel with the AtCRY2-GFP-TopBP1 transfections. As seen in Fig 5C lanes 1 and 2, transfection with AtCRY2-GFP with and without light exposure does not cause Chk1 phosphorylation. In contrast, transfection with AtCRY2-GFP-TopBP1 induces Chk1 phosphorylation even with low level of DNA in the transfection assay and in a manner that is strongly dependent upon blue light exposure. At relatively high plasmid levels, some Chk1 phosphorylation is observed in the absence of light exposure (Fig 5C lanes 7 and 9) , in agreement with previous reports that high level expression of TopBP1 induces Chk1 phosphorylation (18, 27) . However, even under these conditions light exposure increases Chk1 phosphorylation markedly over the dark controls (compare lanes 7 and 8, and lanes 9 and 10) . Secondly, to demonstrate that the blue-lightinduced checkpoint activation was due to clustering of TopBP1 in photobodies we used the mutated AtCRY2 (D387A) as a control. The D387A mutation in the FAD binding pocket completely eliminates FAD binding to AtCRY2 and photobody formation (8) . We constructed AtCRY2(D387A)-GFP-TopBP1 (Fig  5D) , transfected HEK293T cells with this plasmid, exposed cells to blue light and examined photobody formation by immunofluorescence and checkpoint activation by western blotting against Chk1 phosphorylation. The mutant protein, like wild-type exhibits uniform nuclear localization in the dark control, but in contrast to wild-type, it does not form photobodies upon blue-light exposure (Fig 5E) and does not activate Chk1 phosphorylation (Fig 5F) in the absence or presence of blue light (Fig 5F, lanes 5 and 6) under conditions conducive to activation by the wild-type (Fig 5F, lanes 3 and 4) . Taken together, our data lead us to conclude that by fusing the ATR co-activator TopBP1 to AtCRY2 we have developed a unique system of activating the ATRChk1 checkpoint signaling pathway with blue light in the absence of DNA damage.
DISCUSSION
In recent years, a number of methods have been developed that use photosensory proteins for regulating biological functions at the cellular and even organismal levels (29,30). These include channelopsin which employs retinal, phytochromes which employ a linear bilin, and LOV domain proteins which employ FMN as chromophores. With all these systems, lightinduced conformational changes in the photosensory protein itself, or in the target protein such as Raf fused to the chromophore binding module of the photosensory protein, initiate a chain of events that leads to activation of a particular signal transduction pathway or regulation of a specific biochemical network.
In addition to conformational change-induced regulation of activity, light is also known to induce complex formation of two plant photosensory proteins, the red-light sensor phytochrome and the blue-light sensor cryptochrome with their effector target proteins (4, 11) . In both cases, light also induced the formation of large protein aggregates (0.1 to 0.5 µm in diameter) which have many features in common with other nuclear bodies and because their formation is strictly light-dependent they have been named photobodies (4) . Although it is unclear at present whether photobody formation is an essential step on the activation pathway of these photoreceptors, in both cases COP1 E3 ligase is associated with photobodies and photobody formation is followed by degradation of the photosensory protein by the proteasome. Hence, currently available evidence is consistent with photobodies consisting of proteins in aggregates destined for dismantling and thus the deactivation of the light-activated signaling pathway. Formation of phytochrome photobodies appears to depend on participation of several other proteins, one of which is a polyubiquitin binding protein-like, hemera (10). Whether or not cryptochrome photobody formation requires other proteins is not known. Previously, AtCRY2 was expressed in human cells, and upon blue-light excitation was shown to interact with the coexpressed plant transcription factor, CIB1, in a manner similar to what is observed during bluelight signaling in Arabidopsis (31) . However, in that study neither the association of AtCRY2 with endogenous human COP1 nor its proteolysis was investigated.
Here, we show that (1) AtCRY2 forms photobodies in the nuclei of human cells (2). Photobody formation is followed by proteolysis. (3) Photobodies of AtCRY2 contain COP1 in mammalian cells as observed in plant cells, and (4) importantly, we show that by fusing AtCRY2 to a checkpoint protein, we can activate the DNA damage checkpoint signaling pathway in the absence of DNA damage. It is likely that recruitment of other checkpoint proteins to TopBP1 leads to high local concentration of ATR checkpoint complex in the photobodies, which is sufficient to activate the downstream signaling events. Hence, it will be informative to use our optogenetic system to quantitatively study the ATR-mediated cell cycle checkpoints at high spatial resolution in further studies.
We note that while this manuscript was in preparation another group reported AtCRY2 photobody formation in human cells (32) . In that study, AtCRY2 with a deletion of the nuclear localization signal in the C-terminal extension of the cryptochrome was used. As a result, cytoplasmic photobodies were formed, and by fusing this form of AtCRY2 with appropriate proteins, specific membrane/cytoplasmic signaling pathways could be regulated. That study did not address the issue of photobody composition or the issue of light-induced proteolysis of AtCRY2 in mammalian cells. Nevertheless, technologically, the two studies are complementary in terms of one providing a method for activation of intra-nuclear (this work) and the other for activation of cytoplasmic/membrane-associated (32) signaling pathways by light pulses. Since protein clustering regulates numerous signaling pathways, lightinduced AtCYR2 photobody will be a powerful tool to study various cellular events. Bottom panel, the rest were exposed to blue light for 1 hr, fixed and visualized by DAPI staining and fluorescence microscopy. The numbers in parentheses indicate the percent of cells that contained nuclear photobodies. These numbers were obtained from the lower magnification field (3 left columns) and the last column shows selected frames to illustrate photobody formation under all three conditions. Bar=5μm. 4. PML bodies do not co-localize with AtCRY2 photobodies in human cells. HEK293T cells were transfected with AtCRY2-GFP and 48 hrs later, were either kept in the dark or exposed to blue light for 1 hr and analyzed by immunofluorescence staining (GFP) or immunohistochemical staining (PML). PML bodies are apparent in both dark and light samples, whereas AtCRY2 is uniformly distributed in the nuclei of the dark samples and forms nuclear bodies (photobodies) upon light exposure. The AtCRY2 photobodies and PML-NBs do not overlap, indicating that PML is not required for formation or is it recruited to AtCRY2 photobodies. Bar=5μm. 
